CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $342,072,960
- in 74 filings, $341.3M under 10b5-1 plans
Net −$342,072,960. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-22 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −240 | $589.50 | $141K | 324,603 |
| 2026-10-22 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −160 | $590.40 | $94K | 324,443 |
| 2026-10-22 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 176,410 | ||
| 2026-10-21 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $117.76 | $1.1M | 333,943 |
| 2026-10-21 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −46 | $552.52 | $25K | 333,897 |
| 2026-10-21 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −194 | $553.78 | $107K | 333,703 |
| 2026-10-21 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −550 | $555.19 | $305K | 333,153 |
| 2026-10-21 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −567 | $556.41 | $315K | 332,586 |
| 2026-10-21 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,702 | $557.25 | $948K | 330,884 |
| 2026-10-21 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,137 | $558.32 | $635K | 329,747 |
| 2026-10-21 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −743 | $559.25 | $416K | 329,004 |
| 2026-10-21 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −820 | $560.50 | $460K | 328,184 |
| 2026-10-21 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −200 | $561.44 | $112K | 327,984 |
| 2026-10-21 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −960 | $562.54 | $540K | 327,024 |
| 2026-10-21 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,253 | $563.43 | $706K | 325,771 |
| 2026-10-21 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −768 | $564.63 | $434K | 325,003 |
| 2026-10-21 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −480 | $565.36 | $271K | 324,523 |
| 2026-10-21 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −80 | $566.43 | $45K | 324,443 |
| 2026-10-21 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 185,910 | ||
| 2026-10-20 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $117.76 | $1.1M | 333,943 |
Page 14 of 64 · 1,267 trades